Incyte (NASDAQ: INCY) director exercises options and sells 15K shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
INCYTE CORP director Paul J. Clancy completed an option exercise and share sale. On May 19, 2026, he exercised non-qualified stock options to acquire 15,000 shares of common stock at $84.53 per share and sold 15,000 shares at $94.93 per share in an open-market transaction.
After these transactions, he directly owned 23,741 shares of common stock. This figure includes 2,518 shares issuable from previously reported restricted stock units that have not yet vested.
Positive
- None.
Negative
- None.
Insights
Director executed a routine exercise-and-sell, with a net share reduction.
Director Paul J. Clancy exercised non-qualified stock options for 15,000 Incyte common shares at an exercise price of $84.53 on May 19, 2026. The related derivative position was fully exercised, leaving no remaining options from this grant.
The same day, he sold 15,000 common shares at $94.93 per share in an open-market transaction, resulting in net selling of 15,000 shares. Following these moves, he directly held 23,741 shares, including 2,518 issuable under unvested restricted stock units, suggesting a remaining equity stake despite the sale.
Insider Trade Summary 10b5-1
Net Seller: 15,000 shares ($1,423,950)
Net Sell
3 txns
Insider
Clancy Paul J
Role
null
Sold
15,000 shs ($1.42M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 15,000 | $0.00 | -- |
| Exercise | Common Stock | 15,000 | $84.53 | $1.27M |
| Sale | Common Stock | 15,000 | $94.93 | $1.42M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 0 shares (Direct, null);
Common Stock — 38,741 shares (Direct, null)
Footnotes (1)
- Includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan).
Key Figures
Shares sold: 15,000 shares
Sale price: $94.93/share
Options exercised: 15,000 shares
+4 more
7 metrics
Shares sold
15,000 shares
Common stock sold at $94.93 per share on May 19, 2026
Sale price
$94.93/share
Open-market sale of INCYTE CORP common stock
Options exercised
15,000 shares
Non-qualified stock option exercise at $84.53 on May 19, 2026
Exercise price
$84.53/share
Non-qualified stock option (right to buy) exercise price
Shares held after transactions
23,741 shares
Direct INCYTE CORP common stock ownership following May 19, 2026 trades
Unvested RSU-related shares
2,518 shares
Issuable from previously reported restricted stock units, not yet vested
Option expiration
May 26, 2026
Expiration date of exercised non-qualified stock option
Key Terms
Non-Qualified Stock Option, restricted stock units, open-market sale, derivative exercise/conversion, +1 more
5 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
restricted stock units financial
"shares of common stock issuable pursuant to previously reported restricted stock units that have not vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
beneficial ownership financial
"shares of common stock issuable pursuant to previously reported restricted stock units"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transactions did INCYTE CORP (INCY) director Paul J. Clancy report?
Paul J. Clancy reported exercising options for 15,000 INCYTE CORP shares and selling 15,000 common shares on May 19, 2026. The option exercise used a strike price of $84.53, while the sale occurred at $94.93 per share in an open-market transaction.
What were the key prices in Paul J. Clancy’s recent INCY option exercise and sale?
The Form 4 reports an option exercise price of $84.53 per share for 15,000 INCYTE CORP shares and an open-market sale price of $94.93 per share for 15,000 shares. Both transactions occurred on May 19, 2026, reflecting an exercise-and-sell pattern.